Recombinant Coxiella burnetii Peptide deformylase 2 (def2)
Description
Biological Role of Peptide Deformylase 2 in Coxiella burnetii
PDF enzymes are essential for protein maturation in bacteria, mitochondria, and chloroplasts. In C. burnetii, Def2 likely contributes to:
-
Post-translational processing of proteins required for intracellular replication .
-
Resistance to oxidative stress, as observed in related bacteria where PDF truncation reduces growth rates but enhances metabolic stability .
-
Host-pathogen interactions, given the role of C. burnetii LPS phase variation in immune evasion and virulence .
A. Enzyme Kinetics and Inhibition
-
Activity assays: Spectrophotometric or GC-MS methods measure deformylation rates using synthetic substrates (e.g., formyl-Met-Ala-Ser) .
-
Inhibitor screening: Thiol-actinonin chimeras show promise in blocking plant PDFs , with potential cross-reactivity in bacterial enzymes.
B. Immunogenicity and Vaccine Development
Recombinant C. burnetii proteins (e.g., Com1, Mip) elicit mixed immune responses:
-
Antibody production: Weak or absent in mice immunized with peptide pools, suggesting Def2 may require conformational epitopes for immunogenicity .
-
T-cell activation: Peptide epitopes from PDF homologs induce IFN-γ secretion, a marker of Th1 immunity .
Comparative Analysis of PDFs in Pathogens
Challenges and Future Directions
-
Functional redundancy: C. burnetii may encode multiple PDF isoforms, complicating Def2-specific studies .
-
Diagnostic potential: Recombinant Def2 could improve serological assays, as seen with Com1 (sensitivity: 71–94%) .
-
Therapeutic targeting: PDF inhibitors must avoid cross-reactivity with human mitochondrial enzymes .
Key Research Gaps
Product Specs
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Target Background
KEGG: cbu:CBU_1879
STRING: 227377.CBU_1879
Q&A
What is Coxiella burnetii and why is it significant for studying recombinant proteins?
Coxiella burnetii is an intracellular bacterial pathogen that causes Q fever, a disease that normally presents as a severe flu-like illness in humans. It is classified as a risk group 3 organism due to its high infectivity and disease severity . This pathogen has evolved unique metabolic pathways necessary for replicating within its unusual intracellular niche, which may represent novel therapeutic targets .
C. burnetii's significance for studying recombinant proteins like peptide deformylase 2 stems from:
-
Its ability to replicate within the acidic environment of host cell phagolysosomes
-
The need to understand protein processing mechanisms that enable its intracellular survival
-
The potential to identify novel metabolic pathways that could be targeted for therapeutic intervention
-
The necessity to develop risk group 2 alternatives for laboratory studies through targeted mutagenesis
How does C. burnetii's intracellular lifestyle affect protein expression and processing?
C. burnetii thrives within the acidic environment of host cell phagolysosomes, which necessitates specialized protein expression and processing mechanisms:
-
The bacterium has developed noncanonical metabolic pathways, as evidenced by its ability to synthesize lactate despite lacking annotated synthetic pathways in its genome
-
Central carbon metabolism is critical for intracellular replication, as demonstrated by disruption of genes like CBU0823, which significantly reduced 13C-incorporation into glycolytic and TCA cycle intermediates
-
Protein processing enzymes like peptide deformylase 2 likely function under acidic conditions that would denature proteins from non-acidophilic bacteria
-
Transitions between different growth phases may involve coordinated regulation of protein expression and processing
What expression systems are typically used for recombinant C. burnetii proteins?
Based on published methodologies for C. burnetii proteins, several expression systems have proven effective:
Recombinant expression typically requires optimization of induction conditions, buffer composition, and purification protocols to maintain enzymatic activity, as demonstrated by the successful in vitro activity assays conducted with recombinant GST-CBU1241 and 6xHis-CBU0823 .
What methodological challenges exist in producing active recombinant C. burnetii peptide deformylase 2?
Researchers face several challenges when expressing and purifying active recombinant C. burnetii proteins:
-
Maintaining proper folding under standard laboratory conditions when the native protein functions in an acidic intracellular environment
-
Ensuring correct incorporation of metal cofactors, which are essential for peptide deformylase activity
-
Optimizing expression conditions to prevent formation of inclusion bodies, as observed with other recombinant C. burnetii proteins
-
Developing appropriate activity assays that reflect the unique biochemical environment of the C. burnetii intracellular niche
-
Creating expression constructs that produce soluble protein while maintaining native activity
The research with CBU1241 and CBU0823 reveals that even with successful protein expression, careful enzymatic characterization is necessary to confirm the predicted function of recombinant C. burnetii proteins .
How can researchers assess the enzymatic activity of recombinant def2?
Activity assessment for recombinant peptide deformylase 2 would likely follow approaches similar to those used for other C. burnetii enzymes:
| Assay Type | Methodology | Parameters to Optimize | Data Analysis |
|---|---|---|---|
| Spectrophotometric | Monitoring formyl group release from peptide substrates | pH, temperature, metal cofactors | Kinetic parameters (Km, Vmax) |
| Substrate specificity | Testing various N-formylated peptides | Substrate concentration, incubation time | Comparison of catalytic efficiency |
| Inhibition studies | Testing potential inhibitors | Inhibitor concentration, pre-incubation conditions | IC50 determination, inhibition mechanism |
| Mass spectrometry | Direct detection of deformylated products | Sample preparation, ionization conditions | Product verification and quantification |
When designing these assays, researchers should consider that CBU1241 and CBU0823 required specific conditions for detectable activity, and multiple assay formats (LDH activity, malolactic enzyme activity) were needed to characterize their functions comprehensively .
What role might peptide deformylase 2 play in C. burnetii's unique metabolic adaptations?
Peptide deformylase 2 likely contributes to C. burnetii's metabolic adaptations through:
-
Processing of enzymes involved in central carbon metabolism, which is essential for C. burnetii's intracellular replication
-
Deformylation of proteins that function in noncanonical pathways, such as the uncharacterized lactate synthesis pathway identified through stable isotope labeling
-
Maturation of proteins involved in adaptation to the acidic phagolysosomal environment
-
Processing of virulence factors that may be co-regulated with lipopolysaccharide (LPS) phase variation
The importance of properly functioning metabolic enzymes is highlighted by the finding that disruption of CBU0823 significantly reduced 13C-incorporation into glycolytic and TCA cycle intermediates, demonstrating how protein processing could indirectly affect metabolic function .
How does LPS phase variation in C. burnetii potentially impact protein expression and processing?
LPS phase variation represents a virulent-to-avirulent transition in C. burnetii that could affect protein processing:
| LPS Phase | Virulence Status | Genetic Mechanism | Potential Impact on Protein Processing |
|---|---|---|---|
| Phase I | Virulent | Full-length LPS with O-antigen | Normal expression of protein processing machinery |
| Intermediate | Reduced virulence | Partial LPS mutations | Altered regulation of protein synthesis and processing |
| Phase II | Avirulent | LPS truncation, mutations in LPS biosynthesis genes | Possible compensatory changes in protein processing |
The genetic basis of LPS phase conversion involves mutations in multiple genes, suggesting broad transcriptional changes that could affect various cellular processes, including protein maturation pathways . The transition occurs during in vitro passage with similar kinetics across different genomic groups, indicating conserved regulatory mechanisms .
What are the implications of targeting peptide deformylase 2 for developing novel Q fever therapeutics?
Targeting peptide deformylase 2 offers several advantages as a therapeutic strategy:
-
Essential function: As a protein involved in post-translational processing, inhibition could broadly affect bacterial protein maturation
-
Unique bacterial target: No direct homolog exists in human cells, potentially reducing side effects
-
Alternative to current therapies: C. burnetii shows resistance to aminoglycosides and penicillin derivatives that are typically used for empirical treatment
-
Potential for specific inhibitors: The enzyme's structural features could allow design of selective inhibitors
How can site-directed mutagenesis approaches be applied to study def2 functional domains?
Site-directed mutagenesis provides powerful tools for investigating functional domains of C. burnetii proteins:
-
Target selection: Based on sequence analysis and homology modeling with other bacterial peptide deformylases
-
Mutagenesis methodology: Using the C. burnetii lysine auxotrophy system for genetic selection
-
Functional analysis: Comparing enzymatic activities of wild-type and mutant proteins
-
In vivo significance: Assessing effects on bacterial growth and virulence
Recent advances in C. burnetii genetics, including "targeted mutagenesis and genetic complementation using a new C. burnetii nutritional selection system based on lysine auxotrophy," provide the methodological framework for such studies . This approach has been successfully applied to LPS biosynthesis genes, confirming their role in LPS phase variation .
What is the prevalence of C. burnetii infection and what does this mean for def2 research?
Understanding the epidemiological context of C. burnetii infection provides important context for def2 research:
The high prevalence of C. burnetii infection in humans and domestic animals underscores the need for better therapeutic options and highlights the importance of studying essential bacterial enzymes like peptide deformylase 2 that could serve as drug targets .
How can genomic approaches enhance our understanding of def2 function in different C. burnetii strains?
Genomic approaches can provide valuable insights into def2 function across different C. burnetii strains:
-
Comparative genomics: Analyzing def2 sequence conservation across different genomic groups of C. burnetii, similar to studies of LPS phase variation genes
-
Transcriptomic profiling: Examining def2 expression patterns during different growth phases and host cell infection
-
Mutational analysis: Identifying natural variants of def2 and correlating them with phenotypic differences
-
Structural genomics: Predicting functional domains based on sequence analysis and homology modeling
Whole genome sequencing approaches have successfully identified mutations in C. burnetii LPS biosynthesis genes associated with phase variation , suggesting similar approaches could reveal important features of def2 and its role in protein processing.
